Current situation and development trend of biomedical industry in China

Geer Ang; Junyu Chen; Yukai Gu; Weihao Luo; Xiang Li; Siyuan Wang; Sitong Yu; Tongtong Zhou

doi:10.54691/bcpbm.v18i.576

Authors

Geer Ang
Junyu Chen
Yukai Gu
Weihao Luo
Xiang Li
Siyuan Wang
Sitong Yu
Tongtong Zhou

DOI:

https://doi.org/10.54691/bcpbm.v18i.576

Keywords:

Biomedical industry, Investment status, Development status

Abstract

In recent years, China's biomedical industry has developed at an unprecedented speed, and China's biopharmaceutical market is in its early stage of development and has strong growth potential, which is ahead of the overall pharmaceutical market. In this article, we start with the background of the development of China's biomedical industry, elaborate the policy and investment environment for the development of China's biomedical industry, investigate the scale and development trend of China's biomedical industry, and deeply analyze the current situation and development trend of China's biomedical industry.

Downloads

Download data is not yet available.

References

Atkinson, R. D. (2019). China’s Biopharmaceutical Strategy: Challenge or Complement to U.S. Industry Competitiveness? Information Technology and Innovation Foundation. https://itif.org/publications/ 2019/08/12/chinas-biopharmaceutical-strategy-challenge-or-complement-us-industry.

Chen, J. (2014). On perfection of regulation system of patent drugs and generic drugs in China - From the perspective of American experience. Dissertation, East China University of Political and Law. (in Chinese).

Chen, X., Xue, S., Lv, M., & Wang, R. (2019). Pharmaceutical Industry in China: Policy, Market and IP. In K.-C. Liu & U. S. Racherla (Eds.), Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors (pp. 215–250). Springer. https://doi.org/10.1007/978-981-13-8102-7_10.

Ping An Securities Research Institute. (2020). Biomedical Industry 2021 Annual Strategy Report. (in Chinese)

Strategizing on Volume-based Procurement in China. (n. d.). Simon-Kucher. Retrieved July 16, 2021, from https://www.simon-kucher.com/en-us/blog/embracing-change-strategizing-volume-based-procurement - china.

Wong, J., & Fei, X. (n.d.). Life Science Innovation in China. The National Bureau of Asian Research (NBR). Retrieved July 12, 2021, from https://www.nbr.org/publication/life-science-innovation-in-china/

World Health Organization. (2017). China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health.